Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Xenon Pharmaceuticals (XENE) PT Raised to $66 at Stifel
-
News Corp. (NWSA) PT Lowered to $41 at Guggenheim
-
BofA: 'We raise Taiwan’s 2026 GDP growth forecast to 8.0%, from 4.5% previously'
-
-
-
-
-
-
-
Ventas (VTR) PT Raised to $100 at Goldman Sachs
-
-
-
-
-
-
-
Evercore ISI Reiterates Outperform Rating on Expedia (EXPE), 'one of our Top Large Cap Longs'
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $13 at BofA Securities
-
-
-
-
-
-
-
Pfizer (PFE) PT Lowered to $33 at Freedom Capital Markets
-
-
-
-
-
-
-
BTIG on Moonlake Immunotherapeutics (MLTX): 'An Underappreciated and Large Market Opportunity in Rheumatology'
-
-
-
-
-
-
-
Dutch Bros (BROS) Reiterated at Buy by UBS: Remains a Top Pick
-
-
-
-
-
456,764 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.
